Applied BioCode introduces high throughput SARS-CoV-2 Assay
The new BioCode SARS-CoV-2 has been designed to run on the BioCode MDx-3000, an automated molecular diagnostic system
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Apr 20
The new BioCode SARS-CoV-2 has been designed to run on the BioCode MDx-3000, an automated molecular diagnostic system
24 Apr 20
HTL-STREFA's intent is to ensure all caregivers providing finger-stick (capillary blood) testing for COVID-19 antibodies understand how best…
The partnership is offering Coronavirus (COVID-19) IgM/IgG Dual Antibody Rapid Test Kits as a member benefit to NFL…
24 Apr 20
Outer Reef Technologies is an ISO 13485 compliant medical device engineering firm. The company named its Omnis design…
24 Apr 20
EVIS X1 supports accurate screening and confident diagnosis through introducing new and easy-to-use technologies to support how gastrointestinal…
24 Apr 20
With the current physical distancing measures in place, Carestream’s mobile solutions play an instrumental role in limiting the…
24 Apr 20
The test is expected to be available by late May on the company’s multiple laboratory-based high throughput analyzers…
24 Apr 20
Expansion of BARDA funding will help fund Cytovale pilot study for innovative rapid sepsis diagnostic system that delivers…
23 Apr 20
It is a real-time RT-PCR-based molecular test that offers fully automated detection of early COVID-19 infections for quick…
23 Apr 20
Cosmopolitan Trial will evaluate the single treatment of electron beam IORT, compared with weeks of standard radiation therapy